Skip to main content
Top
Published in: Journal of Ophthalmic Inflammation and Infection 1/2023

Open Access 01-12-2023 | Research

Investigating the effect of eye drops based on iodine nanoparticles in the treatment of corneal ulcers in rabbit eyes

Authors: Mostafa Feghi, Sharif Makhmalzadeh, Nasrin Masihpour, Mansour Amin, Nader Mortazavinia

Published in: Journal of Ophthalmic Inflammation and Infection | Issue 1/2023

Login to get access

Abstract

Background

Various organisms, such as bacteria, viruses, and fungi, can cause corneal ulcers. One of the leading causes of vision loss and disability worldwide is corneal ulceration. Practical, accessible, and affordable treatment for this disease seems essential.

Materials and methods

Fifteen New Zealand rabbits infected with Staphylococcus aureus (ATCC 25923) corneal ulcers were randomly divided into three groups of five for the present study. (I, II, and III). Group I was used as the control group (without treatment). The second group received an iodine solution (1.25%) without a nanoparticle structure (betadine). The third group received an iodine solution with a nanoparticle structure used as eye drops. Drops in the corneal ulcer group were used five times daily for 14 days.
Microbial counts and disease severity scores were measured on the first, second, fifth, and fourteenth days and compared between groups separately for each disease.

Results

The results showed that the changes in microbial load were significant in the group that received betadine and nanoparticles. The microbial load was further reduced when using iodine nanoparticles than betadine. The betadine and nano-iodine groups significantly reduced the severity of the disease in rabbits with corneal ulcers (p < 0.05). The average changes in disease severity score were 4.8 ± 1.3, -2.6 ± 0.89, and -2.22 ± 1.22 in the untreated, nano iodine, and betadine groups, respectively. However, a significant increase in disease severity was observed in the untreated group (p = 0.001). It shows a significant difference (p < 0.001) between the nano iodine, betadine, and untreated groups. However, the difference in disease severity changes between nano iodine and non-nano iodine groups was insignificant.

Conclusion

Nanoparticle iodine is more effective than non-nanoparticle iodine in reducing bacterial load. In reducing the severity of the disease, both types of iodine were superior to no treatment. But there was no apparent difference between the two groups treated with iodine.
Literature
1.
go back to reference Maree GK, Mirza AA, Admani MU, Talpur KI, Shaikh AA, Zeba N (2019) Frequency of risk factors of infectious keratitis in tertiary care hospital in hyderabad, Pakistan. Pak Armed Forces Med 2019(2):373 Maree GK, Mirza AA, Admani MU, Talpur KI, Shaikh AA, Zeba N (2019) Frequency of risk factors of infectious keratitis in tertiary care hospital in hyderabad, Pakistan. Pak Armed Forces Med 2019(2):373
2.
go back to reference Gross J, Breitenbach J, Baumgartl H, Buettner R (2021). High-performance detection of corneal ulceration using image classification with convolutional neural networks. In: HICSS-54 Proceedings: 54th Hawaii International Conference on System Sciences (HICSS-54) Gross J, Breitenbach J, Baumgartl H, Buettner R (2021). High-performance detection of corneal ulceration using image classification with convolutional neural networks. In: HICSS-54 Proceedings: 54th Hawaii International Conference on System Sciences (HICSS-54)
3.
go back to reference Byrd LB, Martin N. Corneal ulcer. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023 Byrd LB, Martin N. Corneal ulcer. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023
4.
go back to reference Mohammad Z, Torbati PM, Asadi-Amoli F et al (2019) Microbiological profile of corneal ulcers at a tertiary referral center. Med Hypothesis Discov Innov Ophthalmol 8(1):16 Mohammad Z, Torbati PM, Asadi-Amoli F et al (2019) Microbiological profile of corneal ulcers at a tertiary referral center. Med Hypothesis Discov Innov Ophthalmol 8(1):16
5.
go back to reference Puig M, Weiss M, Salinas R, Johnson DA, Kheirkhah A (2020) Etiology and risk factors for infectious keratitis in South Texas. J Ophthalmic Vis Res 15(2):128PubMedPubMedCentral Puig M, Weiss M, Salinas R, Johnson DA, Kheirkhah A (2020) Etiology and risk factors for infectious keratitis in South Texas. J Ophthalmic Vis Res 15(2):128PubMedPubMedCentral
6.
go back to reference Termote K, Joe AW, Butler AL et al (2018) Epidemiology of bacterial corneal ulcers at tertiary centers in Vancouver. BC Can J Ophthalmol 53(4):330–336CrossRefPubMed Termote K, Joe AW, Butler AL et al (2018) Epidemiology of bacterial corneal ulcers at tertiary centers in Vancouver. BC Can J Ophthalmol 53(4):330–336CrossRefPubMed
7.
go back to reference Berkelman RL, Holland B, Anderson R (1982) Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol 15(4):635–639CrossRefPubMedPubMedCentral Berkelman RL, Holland B, Anderson R (1982) Increased bactericidal activity of dilute preparations of povidone-iodine solutions. J Clin Microbiol 15(4):635–639CrossRefPubMedPubMedCentral
8.
go back to reference Barreto R, Barrois B et al (2020) Addressing the challenges in antisepsis: focus on povidone-iodine. Int J Antimicrob Agents 56:106064CrossRefPubMed Barreto R, Barrois B et al (2020) Addressing the challenges in antisepsis: focus on povidone-iodine. Int J Antimicrob Agents 56:106064CrossRefPubMed
9.
go back to reference Grzybowski A, Kanclerz P, Myers WG (2018) The use of povidone-iodine in ophthalmology. Curr Opin Ophthalmol 29(1):19–32CrossRefPubMed Grzybowski A, Kanclerz P, Myers WG (2018) The use of povidone-iodine in ophthalmology. Curr Opin Ophthalmol 29(1):19–32CrossRefPubMed
10.
go back to reference Winkler R (2015) Iodine—a potent antioxidant and the role of Iodine/Iodide in health and disease. Nat Sci 7(12):548 Winkler R (2015) Iodine—a potent antioxidant and the role of Iodine/Iodide in health and disease. Nat Sci 7(12):548
11.
go back to reference Liu S, Dozois MD, Chang CN et al (2016) Prolonged ocular retention of mucoadhesive nanoparticle eye drop formulation enables the treatment of eye diseases using significantly reduced dosage. Mol Pharm 13(9):2897–2905CrossRefPubMed Liu S, Dozois MD, Chang CN et al (2016) Prolonged ocular retention of mucoadhesive nanoparticle eye drop formulation enables the treatment of eye diseases using significantly reduced dosage. Mol Pharm 13(9):2897–2905CrossRefPubMed
12.
go back to reference Laddha UD, Kshirsagar SJ (2021) Formulation of nanoparticles loaded in situ gel for treating dry eye disease: In vitro, ex vivo and in vivo evidence. J Drug Deliv Sci Technol 61:102112CrossRef Laddha UD, Kshirsagar SJ (2021) Formulation of nanoparticles loaded in situ gel for treating dry eye disease: In vitro, ex vivo and in vivo evidence. J Drug Deliv Sci Technol 61:102112CrossRef
13.
go back to reference Zhou H-Y, Hao J-L, Wang S, Zheng Y, Zhang W-S (2013) Nanoparticles in the ocular drug delivery. Int J Ophthalmol 6(3):390PubMedPubMedCentral Zhou H-Y, Hao J-L, Wang S, Zheng Y, Zhang W-S (2013) Nanoparticles in the ocular drug delivery. Int J Ophthalmol 6(3):390PubMedPubMedCentral
15.
go back to reference Hafner A, Lovrić J, Lakoš GP, Pepić I (2014) Nanotherapeutics in the EU: An overview of current and future directions. Int J Nanomed 9:1005–1023 Hafner A, Lovrić J, Lakoš GP, Pepić I (2014) Nanotherapeutics in the EU: An overview of current and future directions. Int J Nanomed 9:1005–1023
16.
go back to reference Pedrotti E, Bonacci E, Kilian R, Pagnacco C, Fasolo A, Anastasi M et al (2022) The role of topical povidone-iodine in the management of infectious keratitis: a pilot study. J Clin Med 11(3):848CrossRefPubMedPubMedCentral Pedrotti E, Bonacci E, Kilian R, Pagnacco C, Fasolo A, Anastasi M et al (2022) The role of topical povidone-iodine in the management of infectious keratitis: a pilot study. J Clin Med 11(3):848CrossRefPubMedPubMedCentral
17.
go back to reference Gregori NZ, Schiffman JC, Miller DM, Alfonso EC (2006) A clinical trial of povidone-iodine (Betadine) versus placebo in the pretreatment of corneal ulcers. Cornea 25(5):558–563CrossRefPubMed Gregori NZ, Schiffman JC, Miller DM, Alfonso EC (2006) A clinical trial of povidone-iodine (Betadine) versus placebo in the pretreatment of corneal ulcers. Cornea 25(5):558–563CrossRefPubMed
18.
go back to reference Bordin P (2020) Corneal ulcer treated with 0.66% nanoemulsion povidone-iodine: a case report. Am. J. Med. Case Rep 21:e919822–1 Bordin P (2020) Corneal ulcer treated with 0.66% nanoemulsion povidone-iodine: a case report. Am. J. Med. Case Rep 21:e919822–1
19.
go back to reference Brozou CG, Karabatakis V, Giannousis M, Mandraveli K, Karkavelas G, Alexiou-Daniel S (2009) The efficacy of intravitreal povidone-iodine application in experimental Staphylococcus epidermis endophthalmitis. Ophthalmic Res 41(4):181–185CrossRefPubMed Brozou CG, Karabatakis V, Giannousis M, Mandraveli K, Karkavelas G, Alexiou-Daniel S (2009) The efficacy of intravitreal povidone-iodine application in experimental Staphylococcus epidermis endophthalmitis. Ophthalmic Res 41(4):181–185CrossRefPubMed
Metadata
Title
Investigating the effect of eye drops based on iodine nanoparticles in the treatment of corneal ulcers in rabbit eyes
Authors
Mostafa Feghi
Sharif Makhmalzadeh
Nasrin Masihpour
Mansour Amin
Nader Mortazavinia
Publication date
01-12-2023
Publisher
Springer Berlin Heidelberg
Published in
Journal of Ophthalmic Inflammation and Infection / Issue 1/2023
Electronic ISSN: 1869-5760
DOI
https://doi.org/10.1186/s12348-023-00367-w

Other articles of this Issue 1/2023

Journal of Ophthalmic Inflammation and Infection 1/2023 Go to the issue